Activist 13D/13G Filings - BELLICUM PHARMACEUTICALS INC (BLCM)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-02-14
6:00 pm
Unchanged
13GBELLICUM PHARMACEUTICALS INC C
BLCM
Ikarian Capital LLC448,101
4.6%
0
(Unchanged)
View
2024-02-14
2:23 pm
Purchase
13GBELLICUM PHARMACEUTICALS INC C
BLCM
ARMISTICE CAPITAL LLC1,078,459
9.99%
122,464increase
(+12.81%)
View
2023-11-24
1:43 pm
Purchase
13DBELLICUM PHARMACEUTICALS INC C
BLCM
BAKER BROS. ADVISORS LP2,365,472
19.99%
167,553increase
(+7.62%)
View
2023-05-05
4:24 pm
Purchase
13DBELLICUM PHARMACEUTICALS INC C
BLCM
BAKER BROS. ADVISORS LP2,197,919
19.99%
2,197,919increase
(New Position)
View
2023-02-14
12:06 pm
Purchase
13GBELLICUM PHARMACEUTICALS INC C
BLCM
ARMISTICE CAPITAL LLC955,995
9.99%
23,943increase
(+2.57%)
View
2023-02-14
11:02 am
Sale
13GBELLICUM PHARMACEUTICALS INC C
BLCM
Ikarian Capital LLC448,101
5.2%
-48,655decrease
(-9.79%)
View
2023-02-09
11:07 am
Sale
13GBELLICUM PHARMACEUTICALS INC C
BLCM
VANGUARD GROUP INC181,843
2.11%
-248,235decrease
(-57.72%)
View
2022-11-18
3:01 pm
Purchase
13DBELLICUM PHARMACEUTICALS INC C
BLCM
BELLICUM PHARMACEUTICALS INC
BLCM
691,639
7.4%
691,639increase
(New Position)
View
2022-02-14
6:31 pm
Purchase
13GBELLICUM PHARMACEUTICALS INC C
BLCM
ARMISTICE CAPITAL LLC932,052
9.99%
491,308increase
(+111.47%)
View
2022-02-14
4:32 pm
Sale
13GBELLICUM PHARMACEUTICALS INC C
BLCM
Ikarian Capital LLC496,756
5.9%
-3,244decrease
(-0.65%)
View
2022-02-09
3:24 pm
Purchase
13GBELLICUM PHARMACEUTICALS INC C
BLCM
VANGUARD GROUP INC430,078
5.12%
430,078increase
(New Position)
View
2021-02-16
5:10 pm
Sale
13GBELLICUM PHARMACEUTICALS INC C
BLCM
ARMISTICE CAPITAL LLC440,744
8%
-1,309,256decrease
(-74.81%)
View
2021-02-16
4:37 pm
Sale
13GBELLICUM PHARMACEUTICALS INC C
BLCM
Boxer Capital LLC265,743
4.99%
-4,867,857decrease
(-94.82%)
View
2021-02-10
3:57 pm
Purchase
13GBELLICUM PHARMACEUTICALS INC C
BLCM
RENAISSANCE TECHNOLOGIES LLC26,631
0.53%
26,631increase
(New Position)
View
2021-01-08
9:57 pm
Purchase
13GBELLICUM PHARMACEUTICALS INC C
BLCM
Ikarian Capital LLC500,000
9.9%
500,000increase
(New Position)
View
2020-02-14
3:42 pm
Purchase
13GBELLICUM PHARMACEUTICALS INC C
BLCM
ARMISTICE CAPITAL LLC1,750,000
3.4%
1,750,000increase
(New Position)
View
2020-02-12
4:07 pm
Purchase
13GBELLICUM PHARMACEUTICALS INC C
BLCM
RENAISSANCE TECHNOLOGIES LLC2,583,840
5.18%
2,583,840increase
(New Position)
View
2020-01-24
5:18 pm
Sale
13DBELLICUM PHARMACEUTICALS INC C
BLCM
BAKER BROS. ADVISORS LP2,491,244
4.99%
-186,574decrease
(-6.97%)
View
2019-09-06
3:36 pm
Sale
13GBELLICUM PHARMACEUTICALS INC C
BLCM
JPMORGAN CHASE & CO
JPM
0
0%
-4,002,294decrease
(Position Closed)
View
2019-08-26
5:20 pm
Purchase
13GBELLICUM PHARMACEUTICALS INC C
BLCM
ARMISTICE CAPITAL LLC3,232,419
6.5%
3,232,419increase
(New Position)
View
Goto 0, 1, Next